| Detected | Trial | Change |
|---|---|---|
| 2026-08-13 | NCT07079462 Comparing 18F-FAPI PET-Guided Abdominal Radiotherapy Combined With Second-Line Standard… |
Enrollment closed, study ongoing |
| 2026-08-09 | NCT06475287 HAIC Combined With TQB2450 and Anlotinib in Second-line Treatment of Advanced… |
overall status: Not Yet Recruiting → Unknown |
| 2026-08-09 | NCT06470672 Study of SHR-A1921 Combined Adebrelimab in HR-positive, HER2-negative Advanced Breast… |
overall status: Not Yet Recruiting → Unknown |
| 2026-08-09 | NCT06088056 A Phase II Study of T-DXd Plus SRT in HER2-positive Breast Cancer Brain Metastases |
overall status: Not Yet Recruiting → Unknown |
| 2026-08-09 | NCT05989425 Surufatinib as Neoadjuvant Treatment for Locally Advanced or Metastatic Differentiated… |
overall status: Recruiting → Unknown |
| 2026-08-09 | NCT05205200 Immune Therapy in HR-positive/HER2-negative Metastatic Breast Cancer(ENIGMA)-BCTOP-L-M02 |
overall status: Recruiting → Unknown |
| 2026-08-05 | NCT07200570 Evaluation of a Vaccine Chatbot on HPV Vaccine Confidence and Hesitancy |
date change Primary completion pushed: 2026-05 -> 2026-11 |
| 2026-08-05 | NCT07200570 Evaluation of a Vaccine Chatbot on HPV Vaccine Confidence and Hesitancy |
date change Completion pushed: 2026-05 -> 2026-11 |
| 2026-08-02 | NCT06525415 Foot Perfusion by Dynamic Contrast Enhanced MRI in Patients With Peripheral Artery Disease |
overall status: Not Yet Recruiting → Unknown |
| 2026-08-02 | NCT06498401 Effectiveness of Gut Microbiota-targeted Diatery Intervention Among People Living With HIV |
overall status: Not Yet Recruiting → Unknown |
| 2026-08-02 | NCT06355037 Dasatinib Combined With Quercetin to Reverse Chemo Resistance in Triple Negative Breast… |
overall status: Recruiting → Unknown |
| 2026-08-02 | NCT05229003 Irinotecan Plus Anlotinib or Further in Combination With Penpulimab for Second-line… |
overall status: Recruiting → Unknown |
| 2026-08-02 | NCT04303988 A Phase II Study of Triple-negative Breast Cancer Brain Metastases. |
overall status: Recruiting → Unknown |
| 2026-07-30 | NCT07268131 TITAN-HCC: Neoadjuvant and Adjuvant QL1706 With TACE in Resectable Hepatocellular… |
Recruitment opened |
| 2026-07-29 | NCT06431997 A Study of the Intervention of Time-restricted Eating in High-risk Populations of GDM |
Trial completed |
| 2026-07-29 | NCT06431997 A Study of the Intervention of Time-restricted Eating in High-risk Populations of GDM |
date change Primary completion pushed: 2026-01 -> 2026-03-23 |
| 2026-07-29 | NCT06431997 A Study of the Intervention of Time-restricted Eating in High-risk Populations of GDM |
date change Completion moved earlier: 2026-12 -> 2026-07-10 |
| 2026-07-29 | NCT06914687 Efficacy of Tirellizumab Combined With Oral, Intravenous and Abdominal Chemotherapy in… |
overall status: Not Yet Recruiting → Active, Not Recruiting |
| 2026-07-29 | NCT06914687 Efficacy of Tirellizumab Combined With Oral, Intravenous and Abdominal Chemotherapy in… |
date change Primary completion moved earlier: 2028-04-01 -> 2026-11-01 |
| 2026-07-29 | NCT06914687 Efficacy of Tirellizumab Combined With Oral, Intravenous and Abdominal Chemotherapy in… |
date change Completion moved earlier: 2028-04-01 -> 2027-11-01 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-13 | NCT07762885 Omission of Adjuvant Radiotherapy in Low- and Intermediate-Risk Ductal Carcinoma In Situ… | Phase 3 | Recruiting |
| 2026-08-13 | NCT07762924 Omission of Adjuvant Radiotherapy in Young Low-Risk Ductal Carcinoma In Situ Following… | Phase 2 | Recruiting |
| 2026-08-13 | NCT07762976 Dynamic Risk-adapted EBV-DNA and MRI-guided De-concurrent Chemotherapy in Nasopharyngeal… | Phase 2 | Recruiting |
| 2026-08-12 | NCT07760844 An Open-Label, Randomized Phase III Study of Trastuzumab Rezetecan With or Without… | Phase 3 | Not Yet Recruiting |
| 2026-08-11 | NCT07757165 The Necessity of Surgery in Patients With mGC Achieving Radiological Response After… | Phase 2 | Recruiting |
| 2026-08-10 | NCT07755423 Stereotactic Body Radiotherapy for the Treatment of Distant Metastases in Thyroid Cancer… | Enrolling by Invitation | |
| 2026-08-07 | NCT07752719 APEX-STROKE CALM-ICH Domain | Phase 3 | Not Yet Recruiting |
| 2026-07-27 | NCT07727343 AI-Guided TURBT for Bladder Cancer | Not Yet Recruiting | |
| 2026-07-21 | NCT07716046 Fulvestaciclib Combined With Anti-HER2 and Endocrine Therapy for HR+/HER2+ Advanced… | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT04790305 | Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative… | Carcinoma Breast | Recruiting |
| NCT06561620 | Befotertinib Adjuvant Therapy in Stage IA2-IB NSCLC Patients | 3-year Disease-free Survival | Recruiting |
| NCT06090994 | Prevention of Recurrence and Metastasis of Colorectal Cancer by Comparing Huaier With… | Colorectal Cancer | Recruiting |
| NCT06195228 | A Retrospective and Prospective Real-world Study of Molecular Typing in the Treatment of… | Advanced Thyroid Cancer Patients Who Received Target Therapy | Recruiting |
| NCT06230055 | Intrathecal Chemotherapy Through Ommaya Reservoir Upon Her-2 Negative Breast Cancer With… | HER2-negative Breast Cancer | Recruiting |
| NCT07445022 | RWS of Tunlametinib in NRAS-Mutant Advanced Melanoma | Melanoma Advanced | Recruiting |
| NCT07711171 | Efficacy and Safety of Canagliflozin in the Treatment of Type 2 Diabetes With Mild… | Type 2 Diabetes Mellitus | Recruiting |
| NCT05860907 | Clinical Study of Huaier Granules in Patients With Advanced Breast Cancer Without… | Breast Cancer Stage IV | Not Yet Recruiting |
| NCT06061692 | Tongxinluo Capsule in the Treatment of Cerebral Small Vessel Disease-A Randomized… | Cerebral Small Vessel Diseases | Not Yet Recruiting |
| NCT06578299 | Inetetamab Combined With Paclitaxel With/Without Pertuzumab for Previously Treated… | Breast Cancer Stage IV | Not Yet Recruiting |
| NCT06665334 | To Explore the Effect of Huaier Granule on the Negative Conversion Rate After the CEA… | Colorectal Cancer | Not Yet Recruiting |
| NCT05871437 | Randomized Controlled Clinical Study on the Reduction of Tumor Marker Levels in Breast… | Breast Cancer | Not Yet Recruiting |
| NCT07358520 | Clinical Study on the Use of Huaier Granules for the Treatment of Proteinuria Related to… | Proteinuria | Not Yet Recruiting |
| NCT07644663 | The Effects of Different Anesthetics on the Brain's Neural Networks | Electroencephalogram (EEG) | Not Yet Recruiting |
| Phase 3 | |||
| NCT03125980 | Perioperative Versus Postoperative CapOX Chemotherapy for Locally Advanced Colon Cancer | Locally Advanced Colon Cancer | Recruiting |
| NCT03941561 | S-1 for 9 Months Versus 1 Year for Stage II Gastric Cancer (SMAC） | Gastric Cancer | Recruiting |
| NCT04997837 | Study of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in… | Gastric Cancer | Recruiting |
| NCT05086614 | Thymosin-alpha 1 for Adjuvant Treatment After Radical Resection of High-risk Stage II and… | Stage II Colorectal Cancer | Recruiting |
| NCT05059379 | Medial vs. Entire Supraclavicular Lymph Node Radiation Therapy for Patients With Invasive… | Breast Cancer | Recruiting |
| NCT05201430 | Neoadjuvant FOLFOXIRI Versus CapeOX Chemotherapy for Local Advanced Rectal Cancer | Rectal Cancer | Recruiting |
| NCT04520074 | Adjuvant Chemotherapy of Three-step Regimen in BRCA1/2 Wide Type Ovarian Cancer (ACTS-2) | Ovarian Cancer | Recruiting |
| NCT05674305 | Radiotherapy Alone Versus Concurrent Chemo-radiotherapy for Nasopharyngeal Carcincoma… | Nasopharyngeal Carcinoma | Recruiting |
| NCT05772208 | Intensified Treatments for Patients With Locally Advanced Nasopharyngeal Carcinoma With… | Nasopharyngeal Carcinoma | Recruiting |
| NCT05901428 | TCb vs EC-T in High Risk ER+/HER2- Breast Cancer | Hormone Receptor Positive HER-2 Negative Breast Cancer | Recruiting |
| NCT05883852 | EC-THP Versus TCbHP in HER2-positive Lymph Node Positive Early Breast Cancer | HER2 Positive Early Breast Cancer | Recruiting |